CSIMarket
 
T2 Biosystems Inc   (TTOO)
Other Ticker:  
 
 

T2 Biosystems Inc Growth Comparisons

Select each growth Category to receive further Information



TTOO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -59.97 % 5.38 % - -0.55 %
Q / Q Revenue Growth (Q3 MRQ) -25.05 % 0.13 % - -1.18 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -53.8 % 6.99 % - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -16.7 % 1.25 % - 0.08 %
Revenue 5 Year Average Growth 36.74 % 7.83 % 10.74 % 11.13 %


TTOO's Growth Comparisons in III. Quarter 2023




As T2 Biosystems Inc 's sales faded by -59.97% year on year in the third quarter 2023, the Medical Equipment & Supplies industry grew by 5.38%, T2 Biosystems Inc 's third quarter 2023 performance was trailing the Medical Equipment & Supplies industry in the third quarter 2023, but less than % no change in the Healthcare sector. Comparing the third quarter sales, T2 Biosystems Inc was trailing overall market not just Medical Equipment & Supplies industry.

Top-line fell by -25.05% from the second quarter results. Comparing the annual growth, sales of 36.74% on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2023 financial results, average yearly sales growth is 11.13%. T2 Biosystems Inc grew faster than the market.


Growth Rates of TTOO's Income in the third quarter 2023


TTOO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - -40.89 % -41.68 % 0.59 %
Seq. Operating Income Change (Q3 MRQ) - - 37.14 % 7.23 %
Y / Y Operating Income Growth (Q3 TTM) - -63.24 % -26.59 % -9.01 %
Seq. Operating Income Growth (Q3 TTM) - -20.89 % -12.38 % -0.23 %
Operating Income 5 Year Avg. Change - -2.43 % 10.15 % 10.86 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - -42.55 % -77.97 % 1.83 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - - 384.2 % 10.6 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -76.48 % -56.82 % -8.43 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - -19.26 % -32.2 % 0.4 %
Income from Cont. Ops. 5 Year Avg. Change - -1.43 % 23.15 % 2.84 %

TTOO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 55.2 % 7.04 % 7.49 %
Q / Q Net Income Growth (Q3 MRQ) - - 2333.8 % 14.75 %
Y / Y Net Income Change (Q3 TTM) - -59.56 % -32.49 % -6.17 %
Seq. Net Income Change (Q3 TTM) - 35.74 % 3.48 % 1.93 %
Net Income 5 Year Avg. Growth - -1.6 % 23.18 % 3.12 %

TTOO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - -59.76 % -77.97 % 1.83 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - - 384.2 % 10.6 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - 117.26 %
EPS from Cont. Ops. 5 Year Avg. Growth - -21 % 23.15 % 2.84 %



TTOO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 8.72 % 7.04 % 2.84 %
Q / Q EPS Net Growth (Q3 MRQ) - - 2333.8 % 14.75 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 60498.58 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - 115.79 %
EPS Net 5 Year Avg. Change - -1.6 % 23.18 % 3.12 %



T2 Biosystems Inc reported bottom-line of $ -3.45 in the third quarter, compare to $ -295.00 in the same quarter a year ago. Medical Equipment & Supplies industry grew by 8.72%, while Healthcare sector increased by 7.04%, and overall market improved by 7.49%.

Bottom-line fell by -25.05% from the second quarter results. Comparing the annual growth, income per share of 36.74% on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2023 earnings, average yearly income per share growth is 3.12%. T2 Biosystems Inc grew faster than the market.

TTOO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 29.38 % 4.9 % 25.82 %
Seq. Free Cash Flow Change (Q3 MRQ) - 21.48 % 51.72 % 28.6 %
Y / Y Free Cash Flow Change (Q3 TTM) - 15.94 % -8.46 % -3.04 %
Seq. Free Cash Flow Change (Q3 TTM) - 6.46 % 2.41 % 11.75 %
Free Cash Flow 5 Year Avg. Change - -4.44 % 18.45 % 23.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) 15.11 % 223.06 % 8.44 % -
Seq. Net Cash Flow Change (Q3 MRQ) 38.01 % 346.31 % - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - 676.43 % 17.06 % -
Net Cash Flow 5 Year Avg. Change - - 0.72 % 48.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -89.68 % 12.73 % 3.34 % 69 %
Seq. Capital Expenditures Change (Q3 MRQ) -60.61 % 16.35 % 5.51 % 16.39 %
Y / Y Capital Expenditures Change (Q3 TTM) -59.76 % 9.04 % 5.42 % -8.14 %
Seq. Capital Expenditures Change (Q3 TTM) -35.87 % 4.67 % 0.77 % 18.42 %
Capital Expenditures 5 Year Avg. Change -32.81 % 9.73 % 9.25 % 8.65 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com